Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SiSi trial of gentamicin-collagen sponge for prevention of groin surgical site infection in vascular surgery
NL-OMON28917Recruiting
- Sponsor
- Atrium Medical Corporation
- Start
- Jul 2012
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of gentamicin in surgical site infection (SSI) (2 arms), sponsored by Atrium Medical Corporation. Primary endpoint: Incidence of groin surgical site infection through postoperative day 30. Started Jul 2012; status: recruiting.
02
Drugs
gentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NL-OMON28917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28917.